Stay updated on Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial page.

Latest updates to the Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page revision/version label was updated from v3.5.2 to v3.5.3, reflecting a change in the ClinicalTrials.gov site build rather than the content of the study record.SummaryDifference0.1%

- Check26 days agoChange DetectedAdded Revision: v3.5.2; removed Revision: v3.5.0.SummaryDifference0.1%

- Check55 days agoChange DetectedThe site was updated from version v3.4.3 to v3.5.0. This release does not change the study content or user-facing information.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No other visible content changes were detected.SummaryDifference0.1%

- Check91 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior government-funding notice (Revision: v3.4.1) from the page.SummaryDifference0.4%

- Check98 days agoChange DetectedAdded a government funding lapse notice affecting site status and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial page.